Nitesh Upadhyay, MD | |
2525 Court Dr, Gastonia, NC 28054-2140 | |
(704) 834-2000 | |
(704) 834-2500 |
Full Name | Nitesh Upadhyay |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 20 Years |
Location | 2525 Court Dr, Gastonia, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841499217 | NPI | - | NPPES |
1841499217 | Medicaid | IA | |
1841499217 | Medicaid | SC | |
515874 | Medicaid | SC |
Facility Name | Location | Facility Type |
---|---|---|
Caromont Regional Medical Center | Gastonia, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Caromont Medical Group Inc | 3577476258 | 328 |
News Archive
As a practicing internist, I need all the help I can get in diagnosing the many diseases that threaten the life and well-being of my patients. So perhaps you'll understand why I'm angered by the reckless new recommendations from the U.S. Preventive Services Task Force (a panel of primary care experts) that I don't use the prostate-specific antigen to screen men older than 40 for prostate cancer.
ReSearch Pharmaceutical Services, Inc., a leading provider of integrated clinical development outsourcing solutions to the biopharmaceutical industry, announces its results for the three and six months ended June 30, 2010. These statements include unaudited comparative results for RPS for the three and six months ended June 30, 2009.
United Therapeutics Corporation announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and autologous stem cell transplantation (ASCT).
As New York, California and other states begin to see their numbers of new COVID-19 cases level off or even slip, it might appear as if we're nearing the end of the pandemic.
The Scripps Research Institute and the University of Pennsylvania School of Medicine have been awarded approximately $8.2 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of tobacco addiction. Of the funds awarded, $5.7 million will go to Scripps Research, and $2.5 million to the University of Pennsylvania.
› Verified 2 days ago
Entity Name | Caromont Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
As a practicing internist, I need all the help I can get in diagnosing the many diseases that threaten the life and well-being of my patients. So perhaps you'll understand why I'm angered by the reckless new recommendations from the U.S. Preventive Services Task Force (a panel of primary care experts) that I don't use the prostate-specific antigen to screen men older than 40 for prostate cancer.
ReSearch Pharmaceutical Services, Inc., a leading provider of integrated clinical development outsourcing solutions to the biopharmaceutical industry, announces its results for the three and six months ended June 30, 2010. These statements include unaudited comparative results for RPS for the three and six months ended June 30, 2009.
United Therapeutics Corporation announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and autologous stem cell transplantation (ASCT).
As New York, California and other states begin to see their numbers of new COVID-19 cases level off or even slip, it might appear as if we're nearing the end of the pandemic.
The Scripps Research Institute and the University of Pennsylvania School of Medicine have been awarded approximately $8.2 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of tobacco addiction. Of the funds awarded, $5.7 million will go to Scripps Research, and $2.5 million to the University of Pennsylvania.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Nitesh Upadhyay, MD Po Box 744786, Atlanta, GA 30374-4786 Ph: (704) 834-2450 | Nitesh Upadhyay, MD 2525 Court Dr, Gastonia, NC 28054-2140 Ph: (704) 834-2000 |
News Archive
As a practicing internist, I need all the help I can get in diagnosing the many diseases that threaten the life and well-being of my patients. So perhaps you'll understand why I'm angered by the reckless new recommendations from the U.S. Preventive Services Task Force (a panel of primary care experts) that I don't use the prostate-specific antigen to screen men older than 40 for prostate cancer.
ReSearch Pharmaceutical Services, Inc., a leading provider of integrated clinical development outsourcing solutions to the biopharmaceutical industry, announces its results for the three and six months ended June 30, 2010. These statements include unaudited comparative results for RPS for the three and six months ended June 30, 2009.
United Therapeutics Corporation announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin (dinutuximab) for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and autologous stem cell transplantation (ASCT).
As New York, California and other states begin to see their numbers of new COVID-19 cases level off or even slip, it might appear as if we're nearing the end of the pandemic.
The Scripps Research Institute and the University of Pennsylvania School of Medicine have been awarded approximately $8.2 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of tobacco addiction. Of the funds awarded, $5.7 million will go to Scripps Research, and $2.5 million to the University of Pennsylvania.
› Verified 2 days ago
Louise Zhou, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2711 X Ray Dr Ste 3701, Gastonia, NC 28054 Phone: 980-834-9600 Fax: 980-834-9605 | |
Anthony R Arn, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2555 Court Dr, Suite 300, Gastonia, NC 28054 Phone: 704-868-3256 Fax: 704-868-5870 | |
Douglas A Nigbor, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr, Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Ajaykumar Narandas Patel, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000 Fax: 704-834-2500 | |
Dr. Yi Zhang, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2544 Court Dr Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Dr. Shawnya Ayers Gore, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1867 Remount Rd, Suite D, Gastonia, NC 28054 Phone: 704-854-8799 Fax: 704-854-8803 | |
Richard Alan Fricker, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2240 Remount Rd, Gastonia, NC 28054 Phone: 704-671-5344 Fax: 704-671-5331 |